NEW INSIGHTS AND NEW APPROACHES FOR THE TREATMENT OF ESSENTIAL-HYPERTENSION - SELECTION OF THERAPY BASED ON CORONARY HEART-DISEASE RISK FACTOR-ANALYSIS, HEMODYNAMIC PROFILES, QUALITY OF LIFE, AND SUBSETS OF HYPERTENSION

被引:88
作者
HOUSTON, MC [1 ]
机构
[1] VANDERBILT UNIV, MED CTR, CTR COOPERAT CARE, MED INTENS CARE UNIT, NASHVILLE, TN 37232 USA
关键词
D O I
10.1016/0002-8703(89)90631-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:911 / 951
页数:41
相关论文
共 398 条
[1]  
ABRAMS WB, 1984, HYPERTENSION, V6, P87
[2]  
AMERY A, 1985, LANCET, V1, P1349
[3]   SERUM-CHOLESTEROL DURING TREATMENT OF HYPERTENSION WITH DIURETIC DRUGS [J].
AMES, RP ;
PEACOCK, PB .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (04) :710-714
[4]   RAISED SERUM-LIPID CONCENTRATIONS DURING DIURETIC TREATMENT OF HYPERTENSION - STUDY OF PREDICTIVE INDEXES [J].
AMES, RP ;
HILL, P .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 55 :S311-S314
[5]   NEGATIVE EFFECTS OF DIURETIC DRUGS ON METABOLIC RISK-FACTORS FOR CORONARY HEART-DISEASE - POSSIBLE ALTERNATIVE DRUG THERAPIES [J].
AMES, RP .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (04) :632-638
[6]   ELEVATION OF SERUM-LIPID LEVELS DURING DIURETIC THERAPY OF HYPERTENSION [J].
AMES, RP ;
HILL, P .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) :748-757
[7]  
AMES RP, 1976, LANCET, V1, P721
[8]  
AMES RP, 1982, J CARDIOVASC PHARM, V4, pS206
[9]   IMPROVEMENT OF GLUCOSE-TOLERANCE AND LOWERING OF GLYCOHEMOGLOBIN AND SERUM-LIPID CONCENTRATIONS AFTER DISCONTINUATION OF ANTIHYPERTENSIVE DRUG-THERAPY [J].
AMES, RP ;
HILL, P .
CIRCULATION, 1982, 65 (05) :899-904
[10]   THE EFFECTS OF ANTIHYPERTENSIVE DRUGS ON SERUM-LIPIDS AND LIPOPROTEINS .1. DIURETICS [J].
AMES, RP .
DRUGS, 1986, 32 (03) :260-278